1. | etbubba | |
2. | northamericandis |
1. | etbubba | |
2. | northamericandis |
1. | northamericandis 04/18/2018 Company to present new Phase 3 data for eptinezumab, Alders lead investigational product candidate for mig… |
2. | northamericandis 05/08/2018 Misses EPS |
3. | etbubba 03/22/2018 Alder BioPharmaceuticals® Appoints Paul B. Cleveland as Interim President and Chief Executive Officer |
4. | etbubba 02/27/2018 Alder BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial and Operating Results |